Burning Rock Biotech (BNR) Earnings Analysis
Burning Rock Biotech (BNR) next reports earnings on 2026-09-02, consensus EPS -2.30601 USD. Last quarter (2026-06-09) it beat with EPS -0.2 USD vs -2.28836 USD est (+91.3%). It has beaten estimates in 4/4 recent quarters (100%). Trailing P/E -1.10.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BNR next report earnings?
| Next earnings date | 2026-09-02 |
|---|---|
| Consensus EPS estimate | -2.30601 USD |
| Revenue estimate | 0.02B |
BNR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-06-09 | -0.2 USD | -2.28836 USD | +91.3% | Beat |
| 2026-03-12 | -0.21 USD | -1.39699 USD | +85% | Beat |
| 2025-11-20 | -0.26 USD | n/a | n/a | n/a |
| 2025-09-08 | -0.15 USD | n/a | n/a | n/a |
| 2025-06-06 | -0.17 USD | n/a | n/a | n/a |
| 2024-12-03 | -0.5 USD | -1.41035 USD | +64.5% | Beat |
| 2024-08-22 | -0.14 USD | -1.48565 USD | +90.6% | Beat |
Beat rate: 4/4 (100%) over reported quarters with consensus data.
BNR valuation and analyst view
| Trailing P/E | -1.10 |
|---|---|
| Trailing EPS | -56.38815 USD |
| Price / book | 0.13 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (3 buy / 0 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Burning Rock Biotech (BNR)'s next earnings date?
Burning Rock Biotech is next scheduled to report on 2026-09-02, with a consensus EPS estimate of -2.30601 USD and revenue estimate of 0.02B.
Did BNR beat earnings last quarter?
In its 2026-06-09 report, BNR posted EPS of -0.2 USD versus a -2.28836 USD estimate — a beat of 91.3%.
What is BNR's earnings track record?
Over the last 4 reported quarters with consensus data, BNR beat estimates 4 times (100%).
What is BNR's current P/E ratio and EPS?
BNR trades at a trailing P/E of -1.10 on trailing EPS of -56.388145276045535 USD.
What do analysts rate BNR?
Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell).